[go: up one dir, main page]

SG11202108821XA - Sghrt polypeptide and related products, methods and uses - Google Patents

Sghrt polypeptide and related products, methods and uses

Info

Publication number
SG11202108821XA
SG11202108821XA SG11202108821XA SG11202108821XA SG11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA
Authority
SG
Singapore
Prior art keywords
sghrt
polypeptide
methods
related products
products
Prior art date
Application number
SG11202108821XA
Inventor
Roger Sik Yin Foo
Dang Vinh Do
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG11202108821XA publication Critical patent/SG11202108821XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202108821XA 2019-02-12 2020-02-12 Sghrt polypeptide and related products, methods and uses SG11202108821XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201901195V 2019-02-12
PCT/SG2020/050069 WO2020167252A1 (en) 2019-02-12 2020-02-12 Sghrt polypeptide and related products, methods and uses

Publications (1)

Publication Number Publication Date
SG11202108821XA true SG11202108821XA (en) 2021-09-29

Family

ID=72045672

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108821XA SG11202108821XA (en) 2019-02-12 2020-02-12 Sghrt polypeptide and related products, methods and uses

Country Status (5)

Country Link
US (1) US12286460B2 (en)
EP (1) EP3924366A4 (en)
CN (1) CN113966341B (en)
SG (1) SG11202108821XA (en)
WO (1) WO2020167252A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025077853A1 (en) * 2023-10-13 2025-04-17 南京安吉生物科技有限公司 Organ fibrosis-related micropeptide (ofmp) and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030176681A1 (en) * 1997-10-24 2003-09-18 Ping Feng 148 human secreted proteins
US20200080081A1 (en) * 2016-12-14 2020-03-12 Agency For Science, Technology And Research A method for regulating the function of a heart cell, related nucleotides and compounds

Also Published As

Publication number Publication date
CN113966341B (en) 2024-09-17
US12286460B2 (en) 2025-04-29
WO2020167252A1 (en) 2020-08-20
CN113966341A (en) 2022-01-21
EP3924366A4 (en) 2023-01-04
US20220227822A1 (en) 2022-07-21
EP3924366A1 (en) 2021-12-22

Similar Documents

Publication Publication Date Title
PT3660045T (en) Polypeptide, process for the production thereof and use thereof
IL277398A (en) Pd-l1 binding affimers, and uses related thereto
IL291299A (en) Anti-tnfr2 antibodies, composotions comprising same and uses thereof
SG11202103781TA (en) Products, uses & methods
IL287781A (en) Clec12a-binding polypeptides and uses thereof
GB2577981B (en) Methods, products & Uses relating thereto
ZA202103259B (en) Modified cas9 protein, and use thereof
GB2591554B (en) Composiitons and methods and uses relating thereto
IL287782A (en) Cd33-binding polypeptides and uses thereof
GB201905674D0 (en) Aquafaba products and methods
GB201813648D0 (en) Methods, products & uses relating thereto
IL287503A (en) Thiosemicarbazates and uses thereof
GB201819200D0 (en) Polypeptide and uses thereof
IL289955A (en) Materials and methods for multidirectional biotransportation
GB201802184D0 (en) Products and methods
IL287386A (en) Promoter sequence and related products and uses thereof
GB201902992D0 (en) Product and method
GB201900253D0 (en) Catalysts and uses thereof
SG11202108821XA (en) Sghrt polypeptide and related products, methods and uses
GB201912016D0 (en) Methods, products & uses relating thereto
IL268971A (en) Polypeptide, polypeptide fragment, derivative thereof, and applications thereof
GB201912021D0 (en) Methods, products & Uses relating thereto
GB201717345D0 (en) Peptides, methods and apparatus
ZA202005050B (en) Polypeptide, compositions and uses thereof
GB2583732B (en) Methods and products